Get the Stockscreener App
2.302
4.30%
0.092
Pulmonx Corp stock is traded at $2.302, with a volume of 226.26K.
It is up +4.30% in the last 24 hours and up +31.71% over the past month.
Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.
See More
Previous Close:
$2.21
Open:
$2.24
24h Volume:
226.26K
Relative Volume:
0.09
Market Cap:
$95.07M
Revenue:
$68.68M
Net Income/Loss:
$-60.84M
P/E Ratio:
-1.4388
EPS:
-1.6
Net Cash Flow:
$-38.42M
1W Performance:
+3.83%
1M Performance:
+31.71%
6M Performance:
-15.26%
1Y Performance:
-64.65%
1-Day Range:
$2.175
$2.3392
1-Week Range:
$2.17
$2.35
52-Week Range:
$1.31
$9.37
Pulmonx Corp Stock (LUNG) Company Profile
Name
Pulmonx Corp
Sector
Industry
Phone
650-364-0400
Address
700 CHESAPEAKE DRIVE, REDWOOD CITY
Compare LUNG with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LUNG
Pulmonx Corp
|
2.305 | 91.16M | 68.68M | -60.84M | -38.42M | -1.60 |
|
ABT
Abbott Laboratories
|
124.34 | 217.86B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
94.86 | 141.35B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
348.75 | 134.41B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
96.24 | 123.15B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
85.28 | 49.47B | 5.88B | 1.34B | 799.60M | 2.3489 |
Pulmonx Corp Stock (LUNG) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-31-25 | Downgrade | Piper Sandler | Overweight → Neutral |
| Mar-10-25 | Initiated | D. Boral Capital | Buy |
| Dec-11-24 | Downgrade | Citigroup | Buy → Neutral |
| Jun-04-24 | Initiated | Lake Street | Buy |
| Feb-23-24 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Sep-05-23 | Initiated | Craig Hallum | Buy |
| Feb-27-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Jan-03-23 | Downgrade | BofA Securities | Neutral → Underperform |
| Dec-12-22 | Upgrade | Citigroup | Neutral → Buy |
| Jul-11-22 | Downgrade | Citigroup | Buy → Neutral |
| Mar-02-22 | Resumed | BofA Securities | Neutral |
| Dec-08-21 | Upgrade | Piper Sandler | Neutral → Overweight |
| Apr-01-21 | Initiated | Citigroup | Buy |
| Mar-25-21 | Initiated | Piper Sandler | Neutral |
| Mar-10-21 | Upgrade | BofA Securities | Neutral → Buy |
| Jan-04-21 | Downgrade | BofA Securities | Buy → Neutral |
| Oct-26-20 | Initiated | BofA Securities | Buy |
| Oct-26-20 | Initiated | Canaccord Genuity | Buy |
| Oct-26-20 | Initiated | Morgan Stanley | Equal-Weight |
| Oct-26-20 | Initiated | Stifel | Buy |
| Oct-26-20 | Initiated | Wells Fargo | Equal Weight |
View All
Pulmonx Corp Stock (LUNG) Latest News
Pulmonx Corporation (NASDAQ:LUNG) Given Consensus Rating of “Hold” by Brokerages - Defense World
Pulmonx Corporation (NASDAQ:LUNG) Given Consensus Rating of "Hold" by Brokerages - MarketBeat
How Leadership Changes And Analyst Revisions Are Shaping Pulmonx's Valuation Story - Yahoo Finance
Pulmonx (NASDAQ:LUNG) Trading Up 2.5%Here's What Happened - MarketBeat
EBITDA per share of Pulmonx Corp. – GETTEX:4NI - TradingView — Track All Markets
What technical charts say about Pulmonx Corporation stockWeekly Stock Summary & AI Enhanced Trade Execution Alerts - Улправда
Why Pulmonx Corporation stock is in analyst buy zoneJuly 2025 PreEarnings & AI Driven Stock Reports - Улправда
Can Pulmonx Corporation stock hit analyst price targetsDay Trade & Reliable Price Action Trade Plans - Улправда
How strong is Pulmonx Corporation stock revenue growthQuarterly Trade Report & Short-Term High Return Ideas - Улправда
Can Pulmonx Corporation stock resist sector downturnsJuly 2025 Drop Watch & Breakout Confirmation Alerts - Улправда
Will Pulmonx Corporation stock deliver better than expected guidanceJuly 2025 Closing Moves & Community Trade Idea Sharing - Улправда
How Pulmonx Corporation stock performs in interest rate cyclesJuly 2025 Patterns & High Conviction Investment Ideas - Улправда
Will Pulmonx Corporation stock continue upward momentumJuly 2025 Opening Moves & Stepwise Trade Signal Guides - Улправда
Pulmonx Navigates Leadership Shift Amidst Mixed Financial Results - AD HOC NEWS
Comparing Careview Communications (OTCMKTS:CRVW) and Pulmonx (NASDAQ:LUNG) - Defense World
What New Catalysts Are Shifting the Pulmonx Story for Investors - Yahoo Finance
Insider Selling: Daniel Florin Sells Shares of Pulmonx Corp (LUN - GuruFocus
Pulmonx Corp Director Daniel P Florin Sells 23,321 Shares - TradingView — Track All Markets
Check out these key findings about Pulmonx Corp (LUNG) - setenews.com
Dir Florin Files To Sell 23,321 Of Pulmonx Corp [LUNG] - TradingView — Track All Markets
Pulmonx (LUNG) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Improved Revenues Required Before Pulmonx Corporation (NASDAQ:LUNG) Stock's 26% Jump Looks Justified - simplywall.st
Insider Selling: Pulmonx (NASDAQ:LUNG) General Counsel Sells 10,278 Shares of Stock - MarketBeat
Pulmonx (NASDAQ:LUNG) CEO Glendon French III Sells 8,805 Shares - MarketBeat
Pulmonx CEO French sells $13.8k in LUNG stock By Investing.com - Investing.com Australia
Pulmonx CEO French sells $13.8k in LUNG stock - Investing.com India
Pulmonx Corp General Counsel Sells Shares to Cover Tax Obligations - TradingView
LUNG FinancialsIncome Statement - Quiver Quantitative
Pulmonx Corporation Grants 1,625,000 Equity Awards as Part of 2025 Inducement Plan - Quiver Quantitative
Pulmonx (Nasdaq: LUNG) issues 1,625,000-share inducement grants, incl. 1.6M RSUs/PSUs - Stock Titan
Pulmonx Corporation (NASDAQ:LUNG) Given Average Recommendation of “Hold” by Brokerages - Defense World
Pulmonx Corporation (NASDAQ:LUNG) Given Average Recommendation of "Hold" by Brokerages - MarketBeat
Check Out Pulmonx Corp (LUNG)’s Trade Data Rather Than the Analysts’ Views - Setenews
Comparing Pulmonx (NASDAQ:LUNG) and Standard BioTools (NASDAQ:LAB) - Defense World
[S-3/A] Pulmonx Corp Amended Shelf Registration Statement | LUNG SEC FilingForm S-3/A - Stock Titan
[S-8] Pulmonx Corp Employee Benefit Plan Registration | LUNG SEC FilingForm S-8 - Stock Titan
Holdings of Pulmonx Corp (LUNG) are aligned with the stars - setenews.com
Pulmonx Corporation (LUNG) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Technical signs of recovery in Pulmonx CorporationQuarterly Market Summary & Daily Chart Pattern Signal Reports - newser.com
Is Pulmonx Corporation stock attractive for hedge fundsWeekly Stock Recap & AI Enhanced Market Trend Forecasts - newser.com
Will Pulmonx Corporation stock sustain high P E ratios2025 Major Catalysts & Growth Focused Entry Reports - newser.com
Pulmonx Corporation (LUNG) stock price, news, quote and history - Yahoo Finance UK
Is Pulmonx Corporation stock trading at a premium valuationAnalyst Downgrade & Fast Entry High Yield Stock Tips - newser.com
A significant driver of top-line growth: Pulmonx Corp (LUNG) - Setenews
Pulmonx (NASDAQ:LUNG) Stock Rating Upgraded by Wall Street Zen - Defense World
Is Pulmonx Corporation stock entering bullish territoryProfit Target & Stepwise Entry/Exit Trade Alerts - newser.com
Can Pulmonx Corporation stock outperform in 2025 bull marketWeekly Trade Recap & Safe Capital Preservation Plans - newser.com
Tick level data insight on Pulmonx Corporation volatility2025 Valuation Update & Precise Buy Zone Identification - newser.com
Historical volatility pattern of Pulmonx Corporation visualizedTrade Analysis Report & Long-Term Safe Return Strategies - newser.com
Pulmonx Corporation (NASDAQ:LUNG) Q3 2025 Earnings Call Transcript - Insider Monkey
Pulmonx (NASDAQ:LUNG) Receives "Buy" Rating from D. Boral Capital - MarketBeat
Pulmonx Corp Stock (LUNG) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.18%
1.06%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):